Factors contributing to the ramifications of this disease as it stands include the socio-economic: overweight and obesity ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 82 tables and 82 figures, this 175-page report ?Global Endoscopy Devices Market 2023-2033 by Device Type, Hygiene, ...

Boston Scientific apparently knows a good bet when it sees one. | That includes treating more than 200,000 patients with the ...

A European research team from Germany, the Czech Republic and Belgium is developing an innovative imaging technology to ...

The company expects its 2025 adjusted earnings to be in the range of $2.80 to $2.87 per share, above analysts' average ...

High-Resolution Insights Into the Brain The holographic endoscope is based on a multimode optical fiber thinner than a human hair. It enables long-term observation of neuronal circuits in deep brain ...

Boston Scientific posted Q4 revenue of $4.56 billion, surpassing estimates. The company forecasts 2025 sales growth of up to 14.5% and EPS of $2.80-$2.87.

Minnesota system treating atrial fibrillation helped sustain Boston Scientific’s streak of bullish results as the company ...

The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall ...

Disposable endoscopes are put into the body through incisions, particularly during arthroscopy, or through natural holes or cavities (such as the anus and mouth). Disposable endoscopes have several ...

Boston Scientific Corporation ( NYSE: BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan - EVP and CFO ...

Boston Scientific Corporation BSX posted fourth-quarter 2024 adjusted earnings per share (EPS) of 70 cents, up 27.3% from the ...